Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.17 CNY | +0.50% |
|
-0.43% | +49.90% |
| 11-25 | Tianjin Pharmaceutical Da Ren Tang Gets China Approval for Pain Relief Patch | MT |
| 11-25 | Tianjin Pharmaceutical Da Ren Tang's Unit Granted Registration Certificate by Chinese Authority | MT |
| Capitalization | 30.85B 4.37B 3.72B 3.47B 3.26B 6.02B 394B 6.56B 40.45B 15.72B 186B 16.4B 16.06B 679B | P/E ratio 2025 * |
15.3x | P/E ratio 2026 * | 31.6x |
|---|---|---|---|---|---|
| Enterprise value | 30.85B 4.37B 3.72B 3.47B 3.26B 6.02B 394B 6.56B 40.45B 15.72B 186B 16.4B 16.06B 679B | EV / Sales 2025 * |
6.29x | EV / Sales 2026 * | 5.77x |
| Free-Float |
31.72% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More news
| 1 day | +0.50% | ||
| 1 week | -0.43% | ||
| Current month | +1.52% | ||
| 1 month | -7.75% | ||
| 3 months | -0.56% | ||
| 6 months | +33.40% | ||
| Current year | +49.90% |
| 1 week | 45.12 |  | 46.76 |
| 1 month | 44.8 | | 50.25 |
| Current year | 28.53 | | 50.97 |
| 1 year | 28.53 | | 50.97 |
| 3 years | 23.4 | | 56.26 |
| 5 years | 17 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 47 | 2023-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 55 | 2017-10-09 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 54 | 2024-11-25 |
Hong Zhou
BRD | Director/Board Member | 55 | 2012-11-30 |
Yoke Pheng Liew
BRD | Director/Board Member | 69 | 2020-06-04 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.50% | -0.43% | +43.39% | +54.05% | 4.35B | |
| -1.10% | -2.56% | -21.38% | -33.76% | 6.37B | |
| +1.03% | +2.54% | -16.62% | +26.96% | 4.4B | |
| -0.96% | -3.80% | +2.70% | -65.62% | 4.18B | |
| -0.50% | +1.35% | -7.12% | -9.40% | 3.64B | |
| -0.07% | -0.33% | +4.30% | +29.74% | 3.23B | |
| -0.12% | -3.08% | -4.04% | -37.18% | 2.45B | |
| +1.99% | -0.93% | +9.03% | -1.32% | 1.95B | |
| -0.70% | +7.64% | +9.50% | +62.99% | 1.81B | |
| -1.60% | -2.17% | -0.51% | +56.00% | 1.75B | |
| Average | -0.15% | +0.12% | +1.93% | +8.25% | 3.41B | |
| Weighted average by Cap. | -0.20% | -0.17% | +0.08% | +1.31% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.91B 695M 592M 552M 518M 958M 62.72B 1.04B 6.44B 2.5B 29.63B 2.61B 2.55B 108B | 5.35B 758M 645M 602M 565M 1.04B 68.35B 1.14B 7.01B 2.72B 32.29B 2.84B 2.78B 118B |
| Net income | 2.32B 329M 280M 262M 245M 454M 29.71B 494M 3.05B 1.18B 14.04B 1.24B 1.21B 51.14B | 1.12B 159M 135M 127M 119M 219M 14.36B 239M 1.47B 573M 6.79B 598M 585M 24.73B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
4,619
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-11 | 46.17 ¥ | +0.50% | 3,196,190 |
| 25-12-11 | 45.94 ¥ | +0.37% | 3,200,834 |
| 25-12-10 | 45.77 ¥ | -0.09% | 3,029,453 |
| 25-12-09 | 45.81 ¥ | -0.09% | 3,572,148 |
| 25-12-08 | 45.85 ¥ | -1.38% | 5,087,845 |
End-of-day quote Shanghai S.E., December 11, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
45.94
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition